Palivizumab Biosimilar - Ultra Low Endotoxin
Product Specifications
Reactivity
Human
Target
RSV-F
Isotype
IgG1
Sequence
https://www.imgt.org/mAb-DB/
Applications
Functional Assays
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
5mg/mL
Endotoxin
≤ 0.1 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE
Buffer
ICH3002
Shipping Conditions
Blue ice
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Specificity
Detects human RSV-F. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Palivizumab.
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Applications Notes
This biosimilar is for research use only (RUO) : it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Isotype Control
Bulk Human IgG1 Isotype Control (IB1) [ICH2254]
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD44 Standard (156-3C11), CF405S conjugate, 0.1mg/mL
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF568 conjugate, 0.1mg/mL
S100A4 (Marker of Tumor Metastasis) (S100A4/1481), CF568 conjugate, 0.1mg/mL
CD50 / ICAM3 (ICAM3/2873R), CF405S conjugate, 0.1mg/mL
Serum Amyloid A (SAA/2868R), CF740 conjugate, 0.1mg/mL
